Efficacy and Safety of Sacubitril/Valsartan by Dose Level Achieved in the PIONEER-HF Trial

OBJECTIVES: To evaluate the efficacy and safety of sacubitril/valsartan according to dose level achieved in the PIONEER-HF trial. BACKGROUND: In patients hospitalized for acute decompensated heart failure (ADHF), in-hospital initiation and continuation of sacubitril/valsartan as compared with enalap...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JACC Heart Fail
Autors principals: Berg, David D., Braunwald, Eugene, DeVore, Adam D., Lala, Anuradha, Pinney, Sean P., Duffy, Carol I., Gurmu, Yared, Velazquez, Eric J., Morrow, David A.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7541586/
https://ncbi.nlm.nih.gov/pubmed/32800511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jchf.2020.06.008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars